MLMarietya I.S. Lauw
Marietya I.S. Lauw
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Marietya I.S. Lauw has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Kuykendall
Moffitt Cancer Center, Tampa, USA
1 shared publication - Bijal D. Shah
Moffitt Cancer Center, Tampa, USA
1 shared publication - Chuanyi Mark Lu
Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
1 shared publication - David A. Sallman
Moffitt Cancer Center and Research Institute, Tampa, Florida, United States
1 shared publication - Endi Wang
Department of Pathology University of Southern California Keck School of Medicine Los Angeles California USA
1 shared publication - Eric Padron
Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
1 shared publication
Latest Publications
- 20 September 2022
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 22, S159
Poster: MPN-521 Somatic Mutational Landscape and Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors Among Patients With Myeloid and Lymphoid Neoplasms With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, FGFR1, JAK2, or FLT3
- 20 September 2022
- Published by Elsevier in Clinical Lymphoma Myeloma and Leukemia
- Vol. 22, S159
Poster: MPN-521 Somatic Mutational Landscape and Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors Among Patients With Myeloid and Lymphoid Neoplasms With Eosinophilia and Rearrangements of PDGFRA, PDGFRB, FGFR1, JAK2, or FLT3
- 12 February 2022
- Published by Elsevier in Human Pathology
- Vol. 123, 11-19
Distinct pathologic feature of myeloid neoplasm with t(v;11p15); NUP98 rearrangement
- 12 February 2022
- Published by Elsevier in Human Pathology
- Vol. 123, 11-19
Distinct pathologic feature of myeloid neoplasm with t(v;11p15); NUP98 rearrangement